A Randomized, Double-blind, Placebo-controlled, Parallel, Multi-center, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
Latest Information Update: 28 Jul 2025
At a glance
- Drugs CJ-15314 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors HK inno.N
Most Recent Events
- 28 Jul 2025 New trial record